Episodebeskrivelse
In this podcast, we show a pivotal shift in 2026 for AI drug discovery toward integrated, AI-native R&D systems that move beyond simple algorithmic tasks to form closed-loop learning environments. In this new phase, the industry focuses on converting physical experiments into causal data to overcome information bottlenecks that mere model scaling cannot solve. Leading experts emphasize that generative abundance is creating a new challenge, making it more difficult to select the right candidate than to design it. Consequently, the bottleneck is migrating from molecular discovery toward…
Website: podcasters.spotify.com

